HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
25 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
ITGA3
integrin subunit alpha 3
Chromosome 17 · 17q21.33
NCBI Gene: 3675Ensembl: ENSG00000005884.19HGNC: HGNC:6139UniProt: A0A140VJM0
288PubMed Papers
21Diseases
0Drugs
29Pathogenic Variants
FUNCTIONAL ROLE
Hub GeneReceptor
RESEARCH IMPACT
Trending
CLINICAL
OMIM Disease Gene
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
protease bindingnephron developmentrenal filtrationprotein heterodimerization activityepidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndromeCongenital nephrotic syndrome-interstitial lung disease-epidermolysis bullosa syndromeneurodegenerative diseasejunctional epidermolysis bullosa
✦AI Summary

ITGA3 encodes integrin subunit alpha 3, which forms heterodimeric transmembrane receptors crucial for cell adhesion, migration, and signaling pathways. The protein primarily functions by forming the α3β1 integrin complex with ITGB1, serving as a receptor for extracellular matrix proteins including laminin and fibronectin 12. ITGA3 plays critical roles in epithelial-mesenchymal transition (EMT) plasticity, with ZIP4-mediated upregulation promoting cancer metastasis through the ZEB1/YAP1-ITGA3 signaling axis 3. The protein also mediates immune interactions, as α3β1 integrin serves as a sialylated glycoprotein ligand for Siglec-10 on tumor-associated macrophages, suppressing macrophage-mediated phagocytosis and promoting immune evasion in pancreatic cancer 2. Additionally, ITGA3 participates in lung cell senescence through THBS1-(ITGA3+ITGB1) signaling during SARS-CoV-2 infection 4. Clinically, ITGA3 overexpression correlates with poor prognosis across multiple cancer types including pancreatic, hepatocellular, and oral squamous cell carcinomas 56. The protein's association with immune infiltration patterns and checkpoint expression suggests potential as both a prognostic biomarker and therapeutic target for cancer immunotherapy 76.

Sources cited
1
ITGA3 interactions with fibronectin (FN1-ITGA3) are involved in papillary thyroid carcinoma cell transition and correlate with reduced relapse-free survival
PMID: 38426403
2
ZIP4 upregulates ITGA3 through ZEB1/YAP1 signaling axis to promote EMT plasticity and metastasis in pancreatic cancer
PMID: 33421513
3
ITGA3 is aberrantly expressed in tumor tissues and correlates with prognosis and immune infiltration across multiple cancers
PMID: 38293430
4
ITGA3 is overexpressed in hepatocellular carcinoma tumor cells and enhances migration, serving as a metastasis-related biomarker
PMID: 39085893
5
ITGA3 is identified as a core gene linked to m6A expression and associated with patient prognosis in pancreatic cancer
PMID: 39434688
6
Integrin α3β1 (ITGA3/ITGB1) serves as a sialylated glycoprotein ligand for Siglec-10, suppressing macrophage phagocytosis in pancreatic cancer
PMID: 41182080
7
ITGA3+ITGB1 mediates lung cell senescence through THBS1 signaling during SARS-CoV-2 infection
PMID: 40712141
8
ITGA3 is overexpressed in oral squamous cell carcinoma, correlates with poor prognosis, and associates with immune cell infiltration and checkpoint expression
PMID: 40820179
Disease Associationsⓘ21
epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndromeOpen Targets
0.79Strong
Congenital nephrotic syndrome-interstitial lung disease-epidermolysis bullosa syndromeOpen Targets
0.77Strong
neurodegenerative diseaseOpen Targets
0.50Moderate
junctional epidermolysis bullosaOpen Targets
0.37Weak
epidermolysis bullosa simplex 4, localized or generalized intermediate, autosomal recessiveOpen Targets
0.37Weak
Junctional epidermolysis bullosa, Herlitz typeOpen Targets
0.37Weak
nephrotic syndromeOpen Targets
0.33Weak
asthmaOpen Targets
0.27Weak
genetic disorderOpen Targets
0.19Weak
type 2 diabetes mellitusOpen Targets
0.18Weak
pancreatic carcinomaOpen Targets
0.15Weak
anemiaOpen Targets
0.12Weak
bronchopulmonary dysplasiaOpen Targets
0.12Weak
Eczematoid dermatitisOpen Targets
0.12Weak
Feeding difficultiesOpen Targets
0.12Weak
gastroesophageal reflux diseaseOpen Targets
0.12Weak
penoscrotal transpositionOpen Targets
0.12Weak
phimosisOpen Targets
0.12Weak
respiratory failureOpen Targets
0.12Weak
neoplasmOpen Targets
0.11Weak
Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndromeUniProt
Pathogenic Variants29
NM_002204.4(ITGA3):c.240dup (p.Pro81fs)Pathogenic
not provided|Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome
★★☆☆2025→ Residue 81
NM_002204.4(ITGA3):c.821G>A (p.Arg274Gln)Likely pathogenic
Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome
★★☆☆2024→ Residue 274
NM_002204.4(ITGA3):c.2070+1G>APathogenic
Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome
★★☆☆2024
NM_002204.4(ITGA3):c.2623C>T (p.Arg875Ter)Likely pathogenic
not provided|Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome|Malignant tumor of esophagus
★★☆☆2022→ Residue 875
NM_002204.4(ITGA3):c.2577_2583+13delPathogenic
Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome
★☆☆☆2025
NM_002204.4(ITGA3):c.1528C>T (p.Arg510Ter)Pathogenic
not provided
★☆☆☆2024→ Residue 510
NM_002204.4(ITGA3):c.446G>A (p.Trp149Ter)Likely pathogenic
Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome
★☆☆☆2024→ Residue 149
NM_002204.4(ITGA3):c.2641G>T (p.Gly881Ter)Likely pathogenic
Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome
★☆☆☆2024→ Residue 881
NM_002204.4(ITGA3):c.2261_2264dup (p.Val756fs)Likely pathogenic
Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome
★☆☆☆2024→ Residue 756
NM_002204.4(ITGA3):c.665-1G>ALikely pathogenic
Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome
★☆☆☆2024
NM_002204.4(ITGA3):c.*32-1G>CLikely pathogenic
Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome
★☆☆☆2024
NM_002204.4(ITGA3):c.493C>T (p.Arg165Ter)Likely pathogenic
Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome
★☆☆☆2024→ Residue 165
NM_002204.4(ITGA3):c.2219+1G>ALikely pathogenic
not provided|ITGA3-related disorder
★☆☆☆2024
NM_002204.4(ITGA3):c.2299delLikely pathogenic
Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome
★☆☆☆2024
NM_002204.4(ITGA3):c.2401-11_2409delLikely pathogenic
Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome
★☆☆☆2024
NM_002204.4(ITGA3):c.1469+2T>ALikely pathogenic
not provided
★☆☆☆2023
NM_002204.4(ITGA3):c.826C>T (p.Arg276Ter)Likely pathogenic
ITGA3-related disorder
★☆☆☆2023→ Residue 276
NM_002204.4(ITGA3):c.2794C>T (p.Arg932Ter)Likely pathogenic
ITGA3-related disorder
★☆☆☆2023→ Residue 932
NM_002204.4(ITGA3):c.1387C>T (p.Arg463Trp)Likely pathogenic
Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome
★☆☆☆2021→ Residue 463
NM_002204.4(ITGA3):c.1912A>T (p.Lys638Ter)Likely pathogenic
not provided
★☆☆☆2021→ Residue 638
View on ClinVar ↗
Related Genes
ACTN4Protein interaction98%ACTN1Protein interaction98%CD151Protein interaction98%COL2A1Protein interaction98%COL4A1Protein interaction98%COL4A2Protein interaction98%
Tissue Expression6 tissues
Lung
100%
Ovary
26%
Heart
25%
Brain
15%
Liver
4%
Bone Marrow
1%
Gene Interaction Network
Click a node to explore
ITGA3ACTN4ACTN1CD151COL2A1COL4A1COL4A2
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted · UniProt P26006
View on AlphaFold ↗
Constraintⓘ
LOEUFⓘ
0.69LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF0.56 [0.46–0.69]
RankingsWhere ITGA3 stands among ~20K protein-coding genes
  • #1,242of 20,598
    Most Researched288 · top 10%
  • #1,830of 5,498
    Most Pathogenic Variants29
  • #5,196of 17,882
    Most Constrained (LOEUF)0.69
Genes detectedITGA3
Sources retrieved25 papers
Response time—
📄 Sources
25▼
1
Spatial transcriptomics reveals prognosis-associated cellular heterogeneity in the papillary thyroid carcinoma microenvironment.
PMID: 38426403
Clin Transl Med · 2024
1.00
2
Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer.
PMID: 33421513
Gastroenterology · 2021
0.90
3
Identifying the prognosis implication, immunotherapy response prediction value, and potential targeted compound inhibitors of integrin subunit α3 (ITGA3) in human cancers.
PMID: 38293430
Heliyon · 2024
0.80
4
Metastasis and basement membrane-related signature enhances hepatocellular carcinoma prognosis and diagnosis by integrating single-cell RNA sequencing analysis and immune microenvironment assessment.
PMID: 39085893
J Transl Med · 2024
0.70
5
Multi-omics analysis and validation of autophagy-related diagnostic biomarker in osteoarthritis.
PMID: 40828304
Ann Med · 2025
0.68